Norges Bank’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$227M Buy
+1,214,240
New +$223M 0.02% 501
2026
Q1
Sell
-1,250,473
Closed -$248M 1269
2025
Q4
$248M Buy
+1,250,473
New +$253M 0.03% 471
2025
Q3
Sell
-1,176,030
Closed -$207M 1416
2025
Q2
$207M Sell
1,176,030
-269,454
-19% -$40.6M 0.03% 474
2025
Q1
$194M Sell
1,445,484
-66,193
-4% -$8.72M 0.03% 460
2024
Q4
$191M Sell
1,511,677
-86,442
-5% -$12.9M 0.03% 483
2024
Q3
$266M Sell
1,598,119
-185,910
-10% -$28.1M 0.04% 400
2024
Q2
$237M Sell
1,784,029
-81,993
-4% -$9.87M 0.04% 403
2024
Q1
$196M Buy
1,866,022
+830,511
+80% +$74.6M 0.03% 449
2023
Q4
$78.3M Buy
1,035,511
+4,785
+0.5% +$303K 0.01% 707
2023
Q3
$67.9M Hold
1,030,726
0.01% 706
2023
Q2
$83.9M Sell
1,030,726
-391,422
-28% -$27.9M 0.02% 631
2023
Q1
$84.5M Buy
1,422,148
+78,020
+6% +$4.34M 0.02% 591
2022
Q4
$65.6M Buy
1,344,128
+24,435
+2% +$1.13M 0.02% 695
2022
Q3
$68.1M Buy
1,319,693
+17,201
+1% +$1.02M 0.02% 648
2022
Q2
$68.5M Buy
1,302,492
+30,261
+2% +$2.11M 0.02% 638
2022
Q1
$109M Sell
1,272,231
-72,316
-5% -$5.94M 0.02% 556
2021
Q4
$110M Buy
1,344,547
+344,562
+34% +$25.2M 0.02% 572
2021
Q3
$66.4M Sell
999,985
-34,684
-3% -$2.46M 0.01% 791
2021
Q2
$69.3M Sell
1,034,669
-58,642
-5% -$3.64M 0.02% 789
2021
Q1
$56.9M Sell
1,093,311
-186,019
-15% -$9.4M 0.01% 902
2020
Q4
$51.1M Buy
1,279,330
+226,692
+22% +$7.32M 0.01% 958
2020
Q3
$25.8M Sell
1,052,638
-289,476
-22% -$7.4M 0.01% 1254
2020
Q2
$24.3M Buy
1,342,114
+7,142
+0.5% +$141K 0.01% 1316
2020
Q1
$19.2M Hold
1,334,972
0.01% 1268
2019
Q4
$50.8M Hold
1,334,972
0.01% 910
2019
Q3
$29.5M Hold
1,334,972
0.01% 1219
2019
Q2
$27.6M Hold
1,334,972
0.01% 1283
2019
Q1
$38.5M Sell
1,334,972
-36,136
-3% -$892K 0.01% 1039
2018
Q4
$23.5M Hold
1,371,108
0.01% 1282
2018
Q3
$39M Hold
1,371,108
0.01% 1059
2018
Q2
$46M Buy
1,371,108
+122,252
+10% +$3.8M 0.02% 892
2018
Q1
$30.3M Buy
1,248,856
+722,273
+137% +$14.4M 0.01% 1142
2017
Q4
$7.98M Buy
526,583
+250,000
+90% +$3.52M ﹤0.01% 1798
2017
Q3
$4.54M Sell
276,583
-1,129,150
-80% -$19.1M ﹤0.01% 1879
2017
Q2
$27.2M Sell
1,405,733
-866,941
-38% -$15.1M 0.01% 1182
2017
Q1
$40.2M Buy
2,272,674
+1,023,010
+82% +$19M 0.02% 852
2016
Q4
$18.5M Buy
1,249,664
+85,821
+7% +$1.54M 0.01% 1371
2016
Q3
$25.2M Buy
1,163,843
+199,632
+21% +$5.2M 0.01% 1072
2016
Q2
$26.7M Buy
964,211
+164,948
+21% +$4.87M 0.01% 1009
2016
Q1
$23.1M Hold
799,263
0.01% 1074
2015
Q4
$24.2M Hold
799,263
0.01% 1044
2015
Q3
$29.5M Buy
799,263
+19,414
+2% +$1M 0.02% 880
2015
Q2
$45.1M Buy
779,849
+19,066
+3% +$974K 0.02% 692
2015
Q1
$37.7M Sell
760,783
-50,498
-6% -$2.36M 0.02% 812
2014
Q4
$41.1M Sell
811,281
-35,971
-4% -$1.88M 0.02% 734
2014
Q3
$50.3M Sell
847,252
-880,174
-51% -$49.1M 0.03% 615
2014
Q2
$81.1M Buy
1,727,426
+863,713
+100% +$39M 0.02% 726
2014
Q1
$37M Hold
863,713
0.02% 737
2013
Q4
$36.4M Sell
863,713
-23,975
-3% -$1.04M 0.02% 731
2013
Q3
$36.6M Hold
887,688
0.02% 732
2013
Q2
$40.9M Buy
+887,688
New +$39.7M 0.03% 603

Other funds holding THC

Norges Bank's THC Position: Q2 2026 in Review

Norges Bank opened a new position in Tenet Healthcare (THC) in Q2 2026: 1,214,240 shares worth $227M. The stake represents 0.02% of the portfolio and ranks #501 among its holdings. This is a return to the name: Norges Bank previously reported a position in THC as recently as Q4 2025.

Norges Bank first reported a position in THC in Q2 2013 and has held it in 51 quarters since. The position peaked at $266M in Q3 2024. 678 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Norges Bank held 1,214,240 shares of Tenet Healthcare worth $227M as of Q2 2026.
  • Tenet Healthcare was a new Norges Bank position in Q2 2026.
  • Tenet Healthcare made up 0.02% of Norges Bank's portfolio in Q2 2026, its #501 holding.
  • Norges Bank first reported a position in Tenet Healthcare in Q2 2013 and has held it in 51 quarters since.
  • Norges Bank's Tenet Healthcare position peaked at $266M in Q3 2024.
  • 678 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Norges Bank's 13F filing for Q2 2026, filed 12 Aug 2026.